PMID: 5321464
Some can cause side effects or interact with other medications
doi:10.1111/cei.13158 [76] Yoon JY, Cha JM, Oh JK, et al
Frequently Asked Questions (FAQs) about Melanotan II How is Melanotan II administered
The identity number of the respective OTU in the NT, GLP-1, DSS, and DSS-GLP-1 groups were 901, 902, 1116, and 958, respectively (Figure 5A, 5B)
The most important serious side effects include acute pancreatitis (severe persistent abdominal pain radiating to the back, though clinical trials found similar pancreatitis rates to comparators), severe dehydration from persistent vomiting or diarrhea (signs include dizziness, decreased urination, extreme thirst), gallbladder disease including cholecystitis or cholelithiasis (right upper quadrant pain, fever, jaundice), severe allergic reactions (difficulty breathing, swelling of face or throat), and severe hypoglycemia when combined with insulin or sulfonylureas (confusion, loss of consciousness, seizures)